Clinical Site 164 — Knoxville, Tennessee

Clinical Site 164 is a clinical research site located in Knoxville, Tennessee, United States 37909-2686.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Site 164 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Retinopathy.

Sponsors: OcuTerra Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Knoxville

Browse all research sites in Tennessee · View every site in Knoxville

• Baptist Hospital West
• Dialysis Clinic Inc - University Nephology
• University of Tennessee Medical Center - UTMCK
• Hanna Cancer Associates - University of Tennessee
• University of Tennessee Knoxville
• Healthy Eating and Activity Laboratory, University of Tennessee
• University Urology
• University Neurology
• University of Tennessee-Knoxville: Jesse Harris Building
• University of Tennessee Medical Center-Adult Cystic Fibrosis Clinic
• Perkins Hall, The University of Tennessee
• University Cardiology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 164?

Clinical Site 164 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 164 conducted?

Clinical Site 164 has 1 clinical trials on record. Their work covers Diabetic Retinopathy.

Is Clinical Site 164 accredited by Crixeo Clinical Trials?

Clinical Site 164 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 164?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.